Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTXPQW1)

DTT Name Hormone unspecific (HOM)
Gene Name HOM
DTT Type
Clinical trial target
 [1]
UniProt ID
NOUNIPROTAC
TTD ID
T48470

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
NV-04 DMNF09S Cardiovascular disease BA00-BE2Z Phase 1 [2]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
NV-07a DMWLQV8 Inflammatory bowel disease DD72 Investigative [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01872078) A Study of AZD4901 in Females With Polycystic Ovary Syndrome. U.S. National Institutes of Health.
2 US patent application no. 2011,0201,626, 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase.
3 UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol. 2008 Feb;128(2):447-54.